You are here

Tom Monroe serves as the CEO of Vaxxilon AG which was established to develop synthetic carbohydrate vaccines. Prior to co-founding Vaxxilon, he held multiple positions over twenty years in the health care industry including at Syntex, F. Hoffmann-La Roche, and Actelion. He holds an SM from the MIT Sloan School of Management.